Goat's Rue

Generic name: Galega Officinalis L.
Brand names: French Lilac, Galega, Goat's Rue, Italian Fitch, Pestilenzkraut (German), Professor-weed

Usage of Goat's Rue

Antibacterial effects

Animal and in vitro data

An in vitro study demonstrated that ethanolic (95%) extracts of G. officinalis inhibited the growth of Enterococcus faecalis and Yersinia enterocolitica. The aqueous alcoholic (60%) extract of G. officinalis inhibited Enterobacter aerogenes, Staphylococcus aureus, E. faecalis, Bacillus subtilis, Serratia marcescens, and Y. enterocolitica.(Pundarikakshudu 2001)

Diuresis

Due to its potential diuretic effects, goat’s rue might be considered for disturbances related to secretion of fluids, such as GI ailments (eg, fermentive dyspepsia, gastrocardiac syndrome, diarrhea). Goat's rue is said to stimulate the adrenal glands and pancreas and to aid in glandular disturbances. However, none of these claims are clinically documented.(Blumenthal 1998, Chevallier 1996)

Galactorrhea

Goat's rue has been shown to increase milk production in lactating animals and in breast-feeding mothers.(Chevallier 1996)

Animal and in vitro data

Goat's rue increases milk secretion from 35% to 50% in cows.(Grieve 1931) Goat's rue is recommended in veterinary medicine to stimulate milk secretion.(Bisset 1994)

Clinical data

In a clinical study, 100 mothers with preterm infants were randomized to receive a galactogogue containing silymarin-phosphatidylserine and galega at a dosage of 5 g/day or placebo from days 3 to 28 postdelivery. Significantly higher milk production was noted with treatment at 7 days and 30 days compared with placebo (P<0.05). Women receiving the galactogogue produced 200 mL (110 to 380 mL) each day compared with 115 mL (60 to 245 mL) with placebo (P<0.0001). Women receiving the galactogogue produced more milk (6,523±5,298 mL) during the study period compared with those receiving placebo (4,136±4,093 mL, P<0.02). No adverse effects were reported.(Zecca 2016)

Hypoglycemic effects

Studies in the 1970s demonstrated that galegine and other guanidine derivatives reduce blood sugar levels.(Chevallier 1996) Metformin, a biguanide used for the management of type 2 diabetes mellitus, is derived from G. officinalis.(Schäfer 1967)

Animal and in vitro data

In a study evaluating effects of rue leaf preparations, alcoholic extracts of goat's rue exhibited hypoglycemic effects in diabetic rabbits.(Shukyurov 1974) Another report found galegine lowered blood sugar 32% in diabetic rats.(Petricic 1982) In another study investigating the mechanism by which fractions of the plant exert hypoglycemic effects, inhibition of glucose transport across monolayers of human intestinal cells occurred in a dose-dependent manner.(Neef 1996) In one study, an extract of G. officinalis normalized leukocyte functionality and reduced apoptosis manifestations in streptozotocin-induced diabetes.(Khokhla 2013) Another report compared the hypoglycemic actions of a dried leaf infusion of G. officinalis with infusions of other plant products.(Lemus 1999) The chromium salt content of goat’s rue may also possess antidiabetic effects.(Bisset 1994)

Clinical data

A review evaluating several alternative therapies for diabetes, including G. officinalis, reported encouraging results regarding new treatment possibilities in diabetes mellitus but noted the need for further research.(Stosic 1993) Goat's rue may be of some value as supportive therapy or in early stages of adult-onset diabetes, with guidance from a physician, but use may not be justified based on severity of the disease, adverse effects/interactions, and the availability of better alternatives.(Blumenthal 1998, Chevallier 1996)

Weight reduction

Several mechanisms have been postulated regarding G. officinalis’ ability to cause weight loss, based on observations in murine models. Although treatment with G. officinalis was accompanied by a transient decrease in food intake in one study, pair-feeding indicated that the effects on body weight were at least partially independent of changes in food intake. Possible mechanisms include the activation of adenosine monophosphate activated protein kinase, enhanced glucose uptake, and inhibition of acetyl-CoA carboxylase. Fatty acid synthesis inhibition and fatty acid oxidation simulation occurs with the inhibition of acetyl-CoA carboxylase.(Mooney 2008)

Animal and in vitro data

In studies investigating the effects of goat’s rue on weight, a reversible, marked weight-reducing effect was demonstrated in mice, regardless of food intake. Postmortem examinations revealed a striking absence of body fat in mice administered goat’s rue.(Palit 1998, Palit 1999) Modifications to galegine, including replacement of the dimethylallyl group by various benzyl substituents, enhanced weight loss ability.(Coxon 2009)

Other uses

Goat's rue has been used as a tonic, liver protectant,(Blumenthal 1998) and platelet aggregation inhibitor.(Atanasov 1999, Atanasov 2000, Atanasov 2002, Atanasov 2016) It may also possess antioxidant effects, which can vary according to the type of extract.(Karakas 2016, Khodadadi 2016) G. officinalis extracts were also noted to have variable cytotoxic activity against glioblastoma and lung adenocarcinoma cell lines. An in vitro study demonstrated that an extract of G. officinalis as well as galegine visually changed the color of melanoma cells and reduced the melanin content.(Lee 2012)

Goat's Rue side effects

Headache, jitteriness, or weakness may occur. Because of its ability to inhibit platelet aggregation, there may be an increased risk of bleeding and bruising with administration of goat’s rue.Atanasov 1999, Atanasov 2000, Atanasov 2002

Before taking Goat's Rue

Avoid use. Information regarding safety and efficacy in pregnancy is lacking. In a study of preterm infants, silymarin in combination with galega enhanced milk production in breast-feeding mothers.Zecca 2016

How to use Goat's Rue

Diabetes

Information is lacking to provide dosing recommendations for goat’s rue in diabetes. Clinical dosing information focuses on metformin, which is derived from goat’s rue.

Galactorrhea

1 teaspoon (5 mL) of dried herb steeped in 1 cup (240 mL) of water administered twice daily.Walker 2011

1 to 2 mL of tincture administered 3 times daily.Walker 2011

Warnings

Toxic effects of goat’s rue have been reported, with most data derived from studies in sheep. Dyspnea, anoxia, and foaming nasal discharge were observed in ewes ingesting doses as small as 0.8 g/kg/day. Hydrothorax, lung congestion, foamy exudates in the bronchioles and trachea, epicardial and endocardial peteChiation, and pericardial effusion were noted in sheep that died. Microscopic alterations in the lungs were also noted.Keeler 1986, Keeler 1988 In 3 sheep with poisoning from G. officinalis, an asphyxic syndrome occurred and led to death within hours.Puyt 1981 Galegine is suspected to be the cause of toxicity.Khodadadi 2016

In a murine model, G. officinalis at doses up to 5 g/kg was not associated with increased mortality or toxic symptoms. In the suBChronic arm of the study, cholesterol, creatine phosphokinase, lactate dehydrogenase, and total and conjugated bilirubin levels were increased in some groups of rats. Reductions in calcium, albumin, albumin/globulin ratio, hematocrit, and white blood cell and platelet counts occurred in some rats.Rasekh 2008

In humans, toxicity has been observed with other guanidine derivatives. Most biguanidine preparations developed in the 1950s have been withdrawn from the market.Bisset 1994 Goat's rue should be used to treat diabetes only under physician supervision due to uncertainty regarding its safety and effectiveness.Blumenthal 1998, Chevallier 1996

What other drugs will affect Goat's Rue

Hypoglycemic medications

Additive blood glucose–lowering effects may occur if using goat’s rue concomitantly with other hypoglycemic medications such as insulin and sulfonylureas.Neef 1996

Antiplatelet/Anticoagulant medications

Because goat’s rue inhibits platelet aggregation, the risk of bleeding may be increased when given concomitantly with other antiplatelet medications or anticoagulants.Atanasov 1999, Atanasov 2000, Atanasov 2002

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords